Mean (SD) annualised hospital admission, outpatient visits and dispensed prescription drug costs (ICD and ATC codes are specified in etable 1)
| CKD stage 4 or 5 (not on dialysis) | Peritoneal dialysis | Haemodialysis | Transplanted | |
|---|---|---|---|---|
| Annual admissions | 1.0 (1.9) | 2.6 (3.3) | 3.6 (3.8) | 0.9 (1.7) |
| Annual hospital days | 6.2 (16.4) | 16.0 (25.1) | 21.4 (40.6) | 4.6 (11.5) |
| Cardiovascular disease | 2.3 (8.3) | 5.4 (15.1) | 8.2 (29.1) | 0.7 (3.7) |
| Malignancy | 0.5 (3.8) | 0.3 (2.2) | 0.7 (7.1) | 0.2 (2.9) |
| Infection | 1.1 (5.2) | 2.6 (7.5) | 6.7 (21.6) | 1.5 (6.6) |
| Annual outpatient visits | 7.8 (6.8) | 28.6 (19.4) | 159.4 (28.8) | 9.6 (10.5) |
| Dialysis | 0 | 15.2 (18.5) | 152.2 (27.4) | 0.1 (0.7) |
| Cardiovascular disease | 0.3 (1.1) | 0.3 (1.2) | 0.3 (0.7) | 0.2 (0.7) |
| Malignancy | 0.4 (2.0) | 0.3 (1.2) | 0.5 (3.3) | 0.4 (2.6) |
| Prescription drug costs, € | 2917 (3690) | 7353 (6870) | 8395 (4286) | 6794 (5134) |
| ESA* | 957 (1805) | 2913 (2510) | 3911 (938) | 268 (952) |
| Antineoplastic and immunomodulating agents | 189 (1105) | 97 (449) | 249 (973) | 5137 (4115) |
| Various | 297 (1675) | 1086 (1357) | 1420 (1460) | 23 (161) |
| Cardiovascular system | 434 (410) | 399 (459) | 285 (329) | 371 (327) |
| Antidepressant drugs | 54 (330) | 42 (179) | 68 (171) | 30 (177) |
| Fluids for peritoneal dialysis,† € | – | 29 900 | – | – |
*For haemodialysis, costs related to ESA were estimated from a smaller sample (n=85) of patients on haemodialysis as ESA use in this patient group does not enter the Prescribed Drug Register as it is administrated in the hospital in conjunction with dialysis.
†Based on a regional report of dialysis care in southern Sweden.31
ATC, Anatomic Therapeutic Chemical; CKD, chronic kidney disease; ESA, Erythropoietin stimulating agents; ICD, International Classification of Diseases.